Scientists have, for the first time, investigated the pharmacological effects of a compound found in a rare moss called liverwort. The compound closely resembles that of THC, but exhibits less of a psychoactive effect with potentially better anti-inflammatory properties.
Continue Reading
The unexplained beneficial effects of cannabis for Crohn's disease sufferers just got stranger with researchers from Israel finding cannabis oil significantly improves patient symptoms yet, unexpectedly, has little effect on reducing gut inflammation.
Continue Reading
As Canada becomes only the second country in the world to legalize recreational marijuana, the world is closely watching. The country will offer the grandest social experiment we have ever seen in drug legalization and may help answer some questions that have been divisively debated for decades.
Continue Reading
Marijuana compounds like cannabidiol (CBD) have been found to impart benefits to the brain without the negative “stoned” side-effects. Now, researchers at King’s College London have shown that CBD could help reset the brain abnormalities found in people suffering from psychosis.
Continue Reading
A new study from scientists at the University of Massachusetts Medical School and the University of Bath has uncovered the first biological mechanism that could potentially explain how cannabis reduces intestinal inflammation.
Continue Reading
Pet pharmaceutical company CannPal is working with the CSIRO to develop better ways to safely administer medicinal cannabis to a variety of pets. The research is developing microencapsulation techniques to make sure the cannabis oils can be delivered to each different animal precisely and safely.
Continue Reading
The results of one of the longest in-depth studies examining cannabis use and chronic pain is raising doubts over whether cannabis reduces pain severity or opioid use. The study is proving controversial as its findings contradict a growing body of research suggesting exactly the opposite.
Continue Reading
In a landmark announcement the FDA has approved a drug consisting of cannabidiol (CBD), to treat 2 forms of severe childhood-onset epilepsies. CBD is derived from marijuana and the FDA’s approval of this new medicine will force the DEA to reschedule the compound from its current restricted level.
Continue Reading
A team of researchers from the University of Western Australia is set to embark on a world-first human clinical trial specifically examining the effects of medicinal cannabis on subjects suffering from chronic insomnia.
Continue Reading
There are already portable breathalyzers that let people put a number to their inebriation. However, what's a person to do if they want to receive a score on how high they are? Well, in the not-too-distant future, they could use the University of Chicago's "Am I Stoned" app.
Continue Reading
See the stories that matter in your inbox every morning